HTR1A and synovial sarcoma: Although the precise mechanism remains unclear, it is hypothesized that 5-HT2A receptor antagonism may indirectly increase serotonin levels, leading to subsequent activation of 5-HT1A receptors, which can potentially contribute to SS [5].